123 related articles for article (PubMed ID: 1674917)
1. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures.
Liljequist S
Eur J Pharmacol; 1991 Jan; 192(1):197-8. PubMed ID: 1674917
[No Abstract] [Full Text] [Related]
2. Possible involvement of NMDA receptor-mediated transmission in barbiturate physical dependence.
Rabbani M; Wright J; Butterworth AR; Zhou Q; Little HJ
Br J Pharmacol; 1994 Jan; 111(1):89-96. PubMed ID: 7912157
[TBL] [Abstract][Full Text] [Related]
3. Competitive NMDA receptor antagonist, CGP 40116, substitutes for the discriminative stimulus effects of ethanol.
Bienkowski P; Stefanski R; Kostowski W
Eur J Pharmacol; 1996 Oct; 314(3):277-80. PubMed ID: 8957246
[TBL] [Abstract][Full Text] [Related]
4. The new competitive NMDA receptor antagonist CGP 40116 inhibits pilocarpine-induced limbic motor seizures and unconditioned motor behaviour in the mouse.
Starr MS; Starr BS
Pharmacol Biochem Behav; 1994 Jan; 47(1):127-31. PubMed ID: 7906888
[TBL] [Abstract][Full Text] [Related]
5. NMDA receptor involvement in imipramine withdrawal-associated effects on swim stress, GABA levels and NMDA receptor binding in rat hippocampus.
Harvey BH; Jonker LP; Brand L; Heenop M; Stein DJ
Life Sci; 2002 May; 71(1):43-54. PubMed ID: 12020747
[TBL] [Abstract][Full Text] [Related]
6. Ethanol withdrawal hyperexcitability in vitro is selectively decreased by a competitive NMDA receptor antagonist.
Ripley TL; Little HJ
Brain Res; 1995 Nov; 699(1):1-11. PubMed ID: 8616595
[TBL] [Abstract][Full Text] [Related]
7. Ethanol withdrawal seizures and the NMDA receptor complex.
Grant KA; Valverius P; Hudspith M; Tabakoff B
Eur J Pharmacol; 1990 Feb; 176(3):289-96. PubMed ID: 2158451
[TBL] [Abstract][Full Text] [Related]
8. The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Jun; 257(3):1146-53. PubMed ID: 1675288
[TBL] [Abstract][Full Text] [Related]
9. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures.
Valverius P; Crabbe JC; Hoffman PL; Tabakoff B
Eur J Pharmacol; 1990 Aug; 184(1):185-9. PubMed ID: 2145177
[TBL] [Abstract][Full Text] [Related]
10. NMDA receptor antagonists inhibit ethanol-produced locomotor stimulation in NMRI mice.
Liljequist S
Alcohol; 1991; 8(4):309-12. PubMed ID: 1678606
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic site of action underlying the ethanol-induced inhibition of norepinephrine release evoked by stimulation of N-methyl-D-aspartate (NMDA) receptors in rat cerebral cortex.
Fink K; Göthert M
Brain Res; 1992 Feb; 572(1-2):27-32. PubMed ID: 1351786
[TBL] [Abstract][Full Text] [Related]
12. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
13. Adaptive changes in the NMDA receptor complex in rat hippocampus after chronic treatment with CGP 39551.
Mennini T; Miari A; Presti ML; Rizzi M; Samanin R; Vezzani A
Eur J Pharmacol; 1994 Dec; 271(1):93-101. PubMed ID: 7698217
[TBL] [Abstract][Full Text] [Related]
14. MK-801 potently inhibits alcohol withdrawal seizures in rats.
Morrisett RA; Rezvani AH; Overstreet D; Janowsky DS; Wilson WA; Swartzwelder HS
Eur J Pharmacol; 1990 Jan; 176(1):103-5. PubMed ID: 2155795
[TBL] [Abstract][Full Text] [Related]
15. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
Löscher W; Hönack D
J Pharmacol Exp Ther; 1991 Feb; 256(2):432-40. PubMed ID: 1671593
[TBL] [Abstract][Full Text] [Related]
16. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
Wedzony K; Czyrak A; Maćkowiak M; Fijał K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):517-27. PubMed ID: 8740145
[TBL] [Abstract][Full Text] [Related]
17. The contribution of the different binding sites of the N-methyl-D-aspartate (NMDA) receptor to the expression of behavior.
Kretschmer BD; Zadow B; Volz TL; Volz L; Schmidt WJ
J Neural Transm Gen Sect; 1992; 87(1):23-35. PubMed ID: 1346965
[TBL] [Abstract][Full Text] [Related]
18. Sensitisation to repeated withdrawal, in mice treated chronically with diazepam, is blocked by an NMDA receptor antagonist.
Dunworth SJ; Stephens DN
Psychopharmacology (Berl); 1998 Apr; 136(3):308-10. PubMed ID: 9566818
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of N-methyl-D-aspartate receptor-dependent afterdischarges in rat dentate gyrus following in vitro ethanol withdrawal.
Morrisett RA
Neurosci Lett; 1994 Feb; 167(1-2):175-8. PubMed ID: 7909930
[TBL] [Abstract][Full Text] [Related]
20. Postischemic blockade of AMPA but not NMDA receptors mitigates neuronal damage in the rat brain following transient severe cerebral ischemia.
Nellgård B; Wieloch T
J Cereb Blood Flow Metab; 1992 Jan; 12(1):2-11. PubMed ID: 1345757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
